Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL756P (RNA, 7SL, cytoplasmic 756, pseudogene) is a human pseudogene classified as miscellaneous non-coding RNA, located on chromosome 17[1]. It is one of many pseudogenes derived from the 7SL RNA gene, the RNA component of the signal recognition particle (SRP), which plays a key role in protein targeting to the endoplasmic reticulum membrane in eukaryotes[3][5]. However, as a pseudogene, RN7SL756P is presumed non-functional: it does not code for a functional RNA or protein product[1][5]. Most 7SL-derived pseudogenes are generated by reverse transcription and integration events, resulting in truncated and/or nonfunctional versions of the parental RNA[5]. While some pseudogenes in general can play regulatory roles in gene expression—such as acting as competing endogenous RNAs (ceRNAs) or miRNA sponges—there is no evidence that RN7SL756P specifically plays such a role[4][6]. There are no known drugs targeting pseudogenes such as RN7SL756P, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 756, pseudogene (RN7SL756P).